Beta-amyloid burden is not associated with rates of brain atrophy. - AlzForum Alzheimer Research Paper of the Week


	Current Papers
	ARF Recommends
	Milestone Papers
	Search All Papers
	Search Comments


	Research News
	Drug News
	Conference News


	AD Hypotheses
		AlzSWAN
		Current Hypotheses
		Hypothesis Factory
	Forums
		Live Discussions
		Virtual Conferences
		Interviews
	Enabling Technologies
		Workshops
		Research Tools
	Compendia
		AlzGene
		AlzRisk
		Antibodies
		Biomarkers
		Mutations
		Protocols
		Research Models
		Video Gallery
	Resources
		Bulletin Boards
		Conference Calendar
		Grants
		Jobs


	Overview
	Diagnosis/Genetics
	Research
	News
	Profiles
	Clinics


	Companies
	Tutorial
	Drugs in Clinical Trials


	About Alzheimer's
		FAQs
	Diagnosis
		Clinical Guidelines
		Tests
		Brain Banks
	Treatment
		Drugs and Therapies
	Caregiving
		Patient Care
		Support Directory
		AD Experiences


	Member Directory
	Researcher Profiles
	Institutes and Labs


	Mission
	ARF Team
	ARF Awards
	Advisory Board
	Sponsors
	Partnerships
	Fan Mail
	Support Us

Home: Papers of the Week

Annotation

	Josephs KA, Whitwell JL, Ahmed Z, Shiung MM, Weigand SD, Knopman DS, Boeve BF, Parisi JE, Petersen RC, Dickson DW, Jack CR. Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol. 2008 Feb;63(2):204-12. PubMed Abstract, View on AlzSWAN

	Comments on Paper and Primary News

	Comment by: Paul Coleman, ARF Advisor
	Submitted 28 September 2007 \| Permalink	Posted 1 October 2007
	I recommend this paper It would be interesting to see a similar study that examined soluble forms of Aβ rather than insoluble forms. View all comments by Paul Coleman

	Comment by: Hilkka Soininen, ARF Advisor
	Submitted 29 September 2007 \| Permalink	Posted 1 October 2007
	I recommend this paper

	Comment by: Yadong Huang
	Submitted 29 September 2007 \| Permalink	Posted 1 October 2007
	I recommend this paper

	Comment by: George Perry, ARF Advisor (Disclosure)
	Submitted 15 October 2007 \| Permalink	Posted 16 October 2007
	I recommend this paper

Submit a Comment on this Paper

Cast your vote and/or make a comment on this paper.

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name
*Last Name
Country or Territory:
*Login Email Address
*Password	Minimum of 8 characters
*Confirm Password
Stay signed in?

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:

*Enter the verification code you see in the picture below:

This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:	Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.

REAGENTS/MATERIAL:
Antibodies used in this study are:
mouse monoclonal anti-Aβ (6F/3D) (Novocastra Vector Labs); mouse monoclonal anti-tau (AT8) (Endogen); mouse monoclonal anti-α-synuclein (LB509) (Zymed); mouse monoclonal anti-neurofilament NF-L (2F11) (Dako); rabbit anti-Ubiquitin (Dako)




			Print this page Email this page Alzforum News Papers of the Week Text size Share & Bookmark Del.icio.us Digg Facebook Google Newsvine








			Antibodies Cell Lines Collaborators Papers Research Participants